Skip to Content
Diagnosed with PsA? Learn about biologics >

Hydrocortisone / neomycin / polymyxin b topical Pregnancy and Breastfeeding Warnings

Hydrocortisone / neomycin / polymyxin b topical is also known as: Cortisporin Cream

Hydrocortisone / neomycin / polymyxin b topical Pregnancy Warnings

Animal studies with this combination drug have not been reported. Corticosteroids have been found to be teratogenic in rabbits when applied topically at concentrations of 0.5% and 15%. There are no controlled data in human pregnancy.

This drug should be used during pregnancy only if the potential benefit outweighs the potential risk to the fetus.

US FDA pregnancy category: Not formally assigned to a pregnancy category.

See references

Hydrocortisone / neomycin / polymyxin b topical Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments:
-Topical application should result in very low levels in breast milk and present negligible risk to the infant.
-Only water-miscible creams or gels should be applied to the breast because ointments may expose the infant to high levels of mineral paraffins via licking.
-Any amount of drug should be wiped off thoroughly prior to nursing if it is being applied to the breast or nipple area.

See references

References for pregnancy information

  1. "Product Information. Cortisporin Cream (hydrocortisone/neomycin/polymyxin B topical)." Monarch Pharmaceuticals Inc, Bristol, TN.

References for breastfeeding information

  1. "Product Information. Cortisporin Cream (hydrocortisone/neomycin/polymyxin B topical)." Monarch Pharmaceuticals Inc, Bristol, TN.
  2. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT." ([cited 2013 -]):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide